US2018100141A1PendingUtilityA1

Multipotent progenitor cell derived from adipose tissue

Assignee: MATSUYAMA AKIFUMIPriority: Jun 14, 2007Filed: Nov 30, 2017Published: Apr 12, 2018
Est. expiryJun 14, 2027(~0.9 yrs left)· nominal 20-yr term from priority
A61P 9/00C12N 5/0667A61P 1/16
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a cell mass containing an adipose-tissue-derived multipotent progenitor cell. Also disclosed is a method for producing an adipose-tissue-derived multipotent progenitor cell from an adipose tissue, which comprises the steps of: (a) removing erythrocytes from an adipose-tissue-derived cell mass to produce a preadipose-tissue-derived multipotent progenitor cell mass; and (b) removing cells other than the adipose-tissue-derived multipotent progenitor cell from the preadipose-tissue-derived multipotent progenitor cell mass to produce the desired adipose-tissue-derived multipotent progenitor cell. Further disclosed is an adipose-tissue-derived multipotent progenitor cell produced by the method.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled) 
     
     
         11 . A method for obtaining a hepatic lobule-like cell cluster, cardiac myoblasts or bone tissue from an Islet-1 expressing adipose tissue-derived multipotent progenitor cell from an adipose tissue, comprising:
 (a) slicing and digesting adipose tissue to make an adipose cell extract of separated cells of adipose tissue-derived cell population;   (b) clarifying the separated cells from naturally occurring tissue and digestion products by centrifugation;   (c) selectively removing erythrocytes from the adipose tissue-derived cell population by the density method, then culturing;   (d) culturing in the presence of feeder cells and then washing the erythrocyte-free clarified adipose tissue-derived cell population;   (e) selectively removing vascular endothelial cells from the cultured and washed erythrocyte-free clarified adipose tissue-derived cell population by a chelator; thereby forming a tissue culture enriched in Islet-1 expressing adipose tissue-derived multipotent progenitor cell population with respect to erythrocytes and respect to vascular endothelial cells, and having a low fibroblast contamination comprising a 23 percent fibroblast cell contamination, and   (f) culturing said tissue culture enriched in Islet-1 expressing adipose tissue-derived multipotent progenitor cell population and obtaining a hepatic lobule-like cell cluster, cardiac myoblasts or bone tissue.   
     
     
         12 . The method according to  claim 11 , wherein the prepared culture lacks erythrocyte cells and vascular endothelial cells and contains feeder cells.

Join the waitlist — get patent alerts

Track US2018100141A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.